KTTA logo

Pasithea Therapeutics (KTTA) Cash From Investing

Annual CFI

$399.00 K
+$3.33 M+113.63%

December 31, 2023


Summary


Performance

KTTA Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKTTAcash flowmetrics:

Quarterly CFI

$0.00
$0.000.00%

September 30, 2024


Summary


Performance

KTTA Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKTTAcash flowmetrics:

TTM CFI

$54.50 K
-$50.20 K-47.95%

September 30, 2024


Summary


Performance

KTTA TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKTTAcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

KTTA Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+113.6%0.0%-48.0%
3 y3 years-+100.0%+108.1%
5 y5 years-+100.0%+108.1%

KTTA Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+113.6%-100.0%+100.0%-87.8%+101.9%
5 y5-yearat high+113.6%-100.0%+100.0%-87.8%+101.9%
alltimeall timeat high+113.6%-100.0%+100.0%-87.8%+101.9%

Pasithea Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(0.0%)
$54.50 K(-47.9%)
Jun 2024
-
$0.00(0.0%)
$104.70 K(-76.7%)
Mar 2024
-
$0.00(-100.0%)
$448.70 K(+12.5%)
Dec 2023
$399.00 K(-113.6%)
$54.50 K(+8.6%)
$399.00 K(-120.7%)
Sep 2023
-
$50.20 K(-85.4%)
-$1.93 M(-10.9%)
Jun 2023
-
$344.00 K(-792.2%)
-$2.16 M(-24.6%)
Mar 2023
-
-$49.70 K(-97.8%)
-$2.87 M(-2.0%)
DateAnnualQuarterlyTTM
Dec 2022
-$2.93 M(>+9900.0%)
-$2.27 M(+1121.1%)
-$2.93 M(+337.1%)
Sep 2022
-
-$185.90 K(-48.7%)
-$669.50 K(+36.0%)
Jun 2022
-
-$362.20 K(+233.8%)
-$492.20 K(+278.6%)
Mar 2022
-
-$108.50 K(+741.1%)
-$130.00 K(+504.7%)
Dec 2021
-$21.50 K
-$12.90 K(+50.0%)
-$21.50 K(+150.0%)
Sep 2021
-
-$8600.00(<-9900.0%)
-$8600.00(<-9900.0%)
Jun 2021
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2021
-
$0.00
$0.00

FAQ

  • What is Pasithea Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Pasithea Therapeutics?
  • What is Pasithea Therapeutics annual CFI year-on-year change?
  • What is Pasithea Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Pasithea Therapeutics?
  • What is Pasithea Therapeutics quarterly CFI year-on-year change?
  • What is Pasithea Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Pasithea Therapeutics?
  • What is Pasithea Therapeutics TTM CFI year-on-year change?

What is Pasithea Therapeutics annual cash flow from investing activities?

The current annual CFI of KTTA is $399.00 K

What is the all time high annual CFI for Pasithea Therapeutics?

Pasithea Therapeutics all-time high annual cash flow from investing activities is $399.00 K

What is Pasithea Therapeutics annual CFI year-on-year change?

Over the past year, KTTA annual cash flow from investing activities has changed by +$3.33 M (+113.63%)

What is Pasithea Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of KTTA is $0.00

What is the all time high quarterly CFI for Pasithea Therapeutics?

Pasithea Therapeutics all-time high quarterly cash flow from investing activities is $344.00 K

What is Pasithea Therapeutics quarterly CFI year-on-year change?

Over the past year, KTTA quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is Pasithea Therapeutics TTM cash flow from investing activities?

The current TTM CFI of KTTA is $54.50 K

What is the all time high TTM CFI for Pasithea Therapeutics?

Pasithea Therapeutics all-time high TTM cash flow from investing activities is $448.70 K

What is Pasithea Therapeutics TTM CFI year-on-year change?

Over the past year, KTTA TTM cash flow from investing activities has changed by -$50.20 K (-47.95%)